Healthcare · Vaccine antigens production

Vaccine antigens production in Egypt in 2026

Egypt does not produce its own vaccine antigens — in 2026 the volume was 0 million doses. Despite ranking 72 out of 197 countries, this reflects the absence of industrial synthesis of active substances. The country imports finished vaccines and antigens from India, China, and Europe, then packages them at state-owned VACSERA facilities. Domestic antigen production remains a strategic goal but requires major biotech investment.

Data for 2026 · unit: million doses
Position

Egypt world ranking

#72 / 197

Country position on the scale from last to first place for this indicator.

EG
#72
#197#1
Trend

Change over time

Change in indicator over the available period.

1
1950
0
1990
0
2000
0
2010
0
2020
0
2025
0
2026

Values — million doses

Related questions

People also search for

Other pages of the reference by this indicator.

Summary

Frequently asked questions

Vaccine antigens production in Egypt — how much?
Based on 2026 data — 0 million doses. This is rank #72 out of 197 countries.
What is Egypt's rank by Vaccine antigens production?
Egypt ranks #72 out of 197 countries in the world ranking by «Vaccine antigens production».
How has Vaccine antigens production changed in Egypt?
Over the available period the indicator changed from 1 to 0 million doses.